This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Keita Kakuda: Innovator in Neurodegenerative Disease Diagnosis
Introduction
Keita Kakuda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of neurodegenerative diseases, particularly in the differentiation between Parkinson's disease and multiple system atrophy. His innovative approach has the potential to enhance diagnostic accuracy and improve patient outcomes.
Latest Patents
Kakuda holds a patent for a method and kit designed to discriminate between Parkinson's disease and multiple system atrophy. The patent outlines a systematic approach that includes preparing a solution containing α-synuclein monomers, adding a biological sample from a subject, allowing the monomers to aggregate, and detecting the resulting α-synuclein aggregates. This method represents a significant advancement in the diagnostic process for these complex conditions. He has 1 patent to his name.
Career Highlights
Keita Kakuda is affiliated with Osaka University, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a commitment to improving diagnostic methods for neurodegenerative diseases, showcasing his dedication to advancing healthcare.
Collaborations
Kakuda collaborates with esteemed colleagues, including Cesar Aguirre Martinez and Kensuke Ikenaka. These partnerships enhance the research environment and contribute to the development of groundbreaking diagnostic techniques.
Conclusion
Keita Kakuda's contributions to the field of neurodegenerative disease diagnosis exemplify the impact of innovation in healthcare. His patented method for distinguishing between Parkinson's disease and multiple system atrophy is a testament to his expertise and commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
